Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is a chronic condition characterized by symptoms or tissue damage resulting from the abnormal retrograde flow of gastric contents into the esophagus. GERD represents a spectrum of disease ranging from uncomplicated reflux symptoms to severe erosive esophagitis and Barrett's esophagus with malignant potential. The prevalence of GERD in Western populations is approximately 20%, with weekly heartburn occurring in 14-20% of adults, making it one of the most common gastrointestinal complaints. GERD has significant economic impact due to healthcare costs and lost productivity, and identifying severe phenotypes (erosive disease, Barrett's esophagus) is critical for cancer surveillance and prevention. Understanding the pathophysiologic mechanisms and appropriate diagnostic strategies is essential for both Step 2 CK examination success and clinical practice across all medical specialties.

GERD results from an imbalance between aggressive factors (acid, pepsin, bile salts) and protective mechanisms of the esophageal mucosa, with defective clearance mechanisms as a central pathophysiologic feature.

The LES is a specialized zone of increased pressure (10-30 mmHg above gastric baseline) maintained by intrinsic smooth muscle tone and extrinsic neural support via the vagus nerve. In GERD, transient lower esophageal sphincter relaxations (tLESRs) represent the primary mechanism in 60-70% of cases; these are brief (5-10 seconds), vagally-mediated relaxations triggered by gastric distension that allow physiologic gastric venting but permit reflux when refluxate is present. Reduced basal LES pressure (<10 mmHg) occurs in 25-30% of GERD patients, often associated with increased body mass index and tobacco use. The LES pressure is regulated by several mechanisms: acetylcholine (via M3 receptors) increases LES pressure, while nitric oxide (NO) and vasoactive intestinal peptide (VIP) mediate tLESRs through decreased smooth muscle tone. Impaired LES closure during swallowing or spontaneous incompetence results in prolonged acid exposure, particularly in recumbent positions.

Esophageal clearance occurs via primary peristalsis (swallow-induced) and secondary peristalsis (distension-induced), with each swallow generating a coordinated wave of smooth muscle contraction that propels the bolus distally. The clearance rate of acid from the esophagus is impaired in GERD patients due to reduced peristaltic amplitude and velocity, abnormal motility patterns, or insufficient salivary buffering. Saliva contains bicarbonate and phosphate buffers that neutralize acid; reduced salivary flow (from medications, Sjögren's syndrome, or radiation) significantly increases esophageal acid exposure time. Gravity plays a critical role in clearance; supine positioning dramatically reduces clearance efficiency and increases reflux frequency. The normal acid clearance time is 5-10 minutes; in GERD patients, particularly those with erosive disease, clearance times exceed 15-20 minutes, allowing prolonged mucosal contact with pH <4.

Parietal cells in the gastric fundus secrete HCl via the H+/K+-ATPase pump, which is responsible for most refluxed acid. Pepsinogen, secreted by chief cells, is converted to pepsin in acidic conditions (pH <3) and is responsible for mucosal protein degradation. The refluxate in GERD contains not only acid and pepsin but also bile salts and pancreatic enzymes, which together are more damaging than acid alone. Cholecystokinase (CCK) and gastrin regulate gastric secretion; basal acid output in GERD patients is typically normal, but some patients have hypersecretion. Bile reflux, occurring when pyloric function is impaired or following gastric surgery, contributes to mucosal injury independent of pH.

The esophageal epithelium is composed of stratified squamous cells (unlike the gastric mucosa which is simple columnar) and depends on multiple protective mechanisms: the epithelial barrier (tight junctions, mucus layer), buffer capacity from saliva and bicarbonate secretion, and mucosal blood flow. Hydrogen ions penetrate through damaged tight junctions between epithelial cells, causing intracellular acidification and triggering apoptosis and inflammatory cascades. Tissue injury activates nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, promoting production of inflammatory cytokines (TNF-α, IL-6, IL-8) and chemokines that recruit immune cells. Repeated acid exposure causes reactive oxygen species (ROS) production, leading to mitochondrial dysfunction and cell death. Impaired mucosal healing, reduced expression of growth factors (EGF, TGF-β), and altered angiogenesis perpetuate tissue damage, particularly in Barrett's esophagus where intestinal metaplasia develops.

The proximal stomach has a capacity to relax and accommodate incoming food (accommodation reflex mediated by NO and VIP) without significant pressure rise; impaired accommodation increases postprandial intragastric pressure and the frequency of tLESRs. Delayed gastric emptying, documented in 25-40% of GERD patients, increases postprandial reflux frequency by maintaining higher intragastric volumes and pressures. Fat-rich meals, caffeine, and alcohol slow gastric emptying via hormonal mechanisms (increased CCK, decreased motilin) and reduce LES pressure, explaining why these are known GERD triggers.

The majority of GERD cases (>90%) are primary, resulting from the pathophysiologic mechanisms described above without an identifiable secondary cause. These patients typically have either tLESR-predominant disease or clearance abnormalities without structural LES incompetence.

Body mass index >30 kg/m² is associated with significantly increased GERD symptoms and erosive esophagitis; the mechanism involves increased intragastric pressure, impaired LES pressure gradient, and increased gastroesophageal pressure differentials during Valsalva or positional changes. Pregnancy increases GERD symptoms in up to 50% of women due to elevated intra-abdominal pressure, progesterone-mediated LES relaxation, and delayed gastric emptying. Tight abdominal binders, heavy lifting, and intense exercise with Valsalva maneuvers increase reflux frequency.

High-fat meals, chocolate, peppermint, and spicy foods decrease LES pressure and/or delay gastric emptying. Caffeine and alcohol directly relax the LES through adenosine receptor antagonism (caffeine) and unknown mechanisms (alcohol). Smoking reduces LES pressure and salivary secretion, doubling GERD risk. Large meal volumes and eating within 3 hours of bedtime increase reflux frequency.

Anticholinergic agents (antihistamines, tricyclic antidepressants) reduce LES pressure; calcium channel blockers (diltiazem, nifedipine) inhibit LES muscle contraction; nitrates cause smooth muscle relaxation; and theophylline antagonizes adenosine receptors, all resulting in decreased LES pressure. NSAIDs and bisphosphonates contribute to esophageal injury through multiple mechanisms.

Type I (sliding) hiatal hernias, the most common (95% of cases), allow intermittent herniation of the gastroesophageal junction above the diaphragm, impairing the extrinsic LES support. While hiatal hernias are present in 40% of the general population, their presence significantly increases GERD risk, particularly when combined with LES dysfunction. Type II (paraesophageal) hernias are less commonly associated with reflux.

Conditions impairing gastric motility—including diabetes mellitus (particularly with autonomic neuropathy), hypothyroidism, scleroderma, and idiopathic gastroparesis—increase postprandial reflux. Medications affecting gastric motility (opioids, anticholinergics) worsen reflux.

Scleroderma and mixed connective tissue disease cause profound LES dysfunction and impaired esophageal peristalsis, leading to severe GERD and frequent complications. Zollinger-Ellison syndrome produces severe reflux due to gastric acid hypersecretion (acid output >15 mEq/hour). Gastric surgery (fundoplication, gastrectomy) alters anatomy and can paradoxically worsen reflux in some patients. Achalasia may present with pseudoreflux symptoms due to retained food fermenting in the esophagus.

Heartburn is the pathognomonic symptom of GERD, characterized as a substernal burning sensation radiating from the epigastrium toward the pharynx. The sensation results from acid irritation of esophageal nociceptors (primarily C-fiber afferents), which communicate pain via vagal and spinal afferent pathways. Heartburn typically occurs postprandially, when supine, or during straining and is relieved by antacids or positional changes. The severity and frequency correlate imperfectly with the degree of esophageal acidification on pH monitoring, indicating heightened sensory perception in some patients (visceral hypersensitivity).

Regurgitation differs from heartburn as a symptom of food or bitter liquid returning into the throat or mouth, often without the associated burning sensation. This occurs when refluxed material reaches the pharynx and represents more severe reflux than heartburn alone. Patients describe bringing up food hours after meals or aspirating during sleep, which particularly concerns for nocturnal GERD and aspiration risk.

Dysphagia (difficulty swallowing) suggests either severe erosive esophagitis with stricture formation or motility disorders coexisting with GERD. Odynophagia (painful swallowing) indicates active mucosal ulceration or, if accompanied by white plaques, possible infectious esophagitis (Candida, HSV) superimposed on GERD. These symptoms warrant upper endoscopy to exclude complications and other diagnoses.

A subset of GERD patients (10-15%) present with atypical symptoms, complicating diagnosis. Chronic cough results from acid stimulation of tracheal and laryngeal receptors via microaspiration; cough may be the sole presenting symptom in "silent GERD." Hoarseness and laryngitis occur from direct laryngeal acid exposure and inflammatory changes. Asthma exacerbation is triggered by acid-induced bronchoconstriction and microaspiration, particularly nocturnal. Noncardiac chest pain may be confused with angina; distinguishing features include relation to meals, position, and antacid response, though overlap with cardiac disease warrants appropriate cardiac evaluation. Dental erosion results from repeated acid exposure of tooth enamel, particularly affecting posterior teeth. Sleep disturbance is common due to nocturnal reflux episodes, often unrecognized by patients.

General examination is typically unremarkable in uncomplicated GERD. Dental erosions may be visible on intraoral inspection, predominantly affecting lingual surfaces of maxillary teeth. Pharyngeal erythema or edema may be present during acute reflux episodes. Signs of complications (severe erosive esophagitis, Barrett's esophagus, strictures) are not clinically detectable on examination. Examination should focus on excluding secondary causes: hirsutism, skin tightness, and sclerodactyly suggest scleroderma; signs of hyperthyroidism or hypothyroidism may point to endocrine etiologies.

Nonerosive reflux disease (NERD) accounts for 60-70% of GERD and presents with typical reflux symptoms but normal endoscopic findings, often representing either milder disease or heightened visceral sensitivity. Erosive esophagitis (15-25% of patients) causes more severe symptoms and visible mucosal damage on endoscopy, with increased risk of Barrett's esophagus and adenocarcinoma. Barrett's esophagus, a precancerous condition discussed in complications, develops in 5-15% of chronic GERD patients. Refractory GERD describes symptoms persisting despite twice-daily proton pump inhibitor (PPI) therapy, occurring in 10-20% of treated patients and reflecting either inadequate acid suppression, non-acid reflux, or functional disorders.

GERD is largely a clinical diagnosis based on characteristic symptoms. The Montreal Consensus defines GERD as "reflux of gastric contents [causing] troublesome symptoms and/or complications." Heartburn and regurgitation occurring ≥2 days per week suggest GERD with reasonable sensitivity (~80%); however, symptoms alone cannot assess severity or presence of complications. A symptom diary documenting frequency, timing, severity, and triggers provides valuable information. Empiric trial of proton pump inhibitors (omeprazole 20 mg daily or equivalent for 2-4 weeks) can serve as a diagnostic test in primary care settings; symptom improvement strongly suggests GERD.

Endoscopy is the gold standard for visualizing esophageal mucosa and detecting erosions, Barrett's esophagus, strictures, or malignancy. The Los Angeles Classification standardizes erosive esophagitis grading: Grade A (isolated mucosal breaks ≤5 mm), Grade B (breaks >5 mm not circumferential), Grade C (circumferential breaks), and Grade D (ulceration with fibrosis/stricture). Endoscopy is not indicated for uncomplicated GERD with typical symptoms, as findings do not correlate with symptom severity and normal endoscopy does not exclude GERD (NERD represents 60-70% of cases). Endoscopy is indicated for: alarm features (dysphagia, odynophagia, weight loss, gastrointestinal bleeding, persistent vomiting), symptoms ≥5-10 years duration (Barrett's screening), or failure to respond to PPI therapy. Endoscopy-based surveillance for Barrett's esophagus involves random 4-quadrant biopsies every 2 cm throughout the metaplastic segment; Prague Criteria quantify the extent of Barrett's (C and M measurements for circumferential and maximal length).

Ambulatory pH monitoring via transnasal catheter or wireless capsule measures esophageal acid exposure over 24-48 hours; normal 24-hour acid exposure (pH <4) is <4.2% of time. This test quantifies reflux severity and correlates acid exposure with symptoms via symptom logs. Indications include: atypical GERD symptoms (chronic cough, hoarseness) to confirm reflux causation before referral for anti-reflux surgery; refractory symptoms despite PPI therapy; assessment before fundoplication; and distinguishing reflux from other causes of chest pain. The DeMeester score combines percent time pH <4, number of reflux episodes, number of prolonged episodes, and longest episode duration; scores >14.7 indicate pathologic acid reflux. Limitations include cost, patient inconvenience, and false reassurance if reflux occurs but is not captured during the monitoring period.

Combined multichannel intraluminal impedance (MII) and pH monitoring simultaneously detects both acid reflux (pH <4) and nonacid reflux events via changes in electrical impedance between electrode pairs. This technique distinguishes acid versus nonacid reflux, liquid versus gas reflux, and upright versus supine events. It is particularly useful in refractory GERD to determine whether PPI-refractory symptoms reflect inadequate acid suppression or true nonacid reflux (which would not respond to further acid suppression). Weakly acidic reflux (pH 4-6) occurs in 30-40% of GERD patients; detection by MII-pH helps guide therapy (e.g., adding baclofen for tLESR reduction rather than additional acid suppression).

Esophageal manometry assesses esophageal peristaltic function and LES pressure using the Chicago Classification (version 3.0). LES pressure is reported as integrated relaxation pressure (IRP) over 4 seconds; normal IRP is <26

Stabilization first (rare but tested): hematemesis, melena, or complete esophageal obstruction from a peptic stricture with food impaction requires IV access, fluid/blood resuscitation, IV PPI infusion, and urgent endoscopy before any outpatient reflux plan is made.

Lifestyle modification (all patients): The ACG 2022 GERD guideline endorses weight loss in overweight patients, elevation of the head of the bed for nocturnal symptoms, avoiding meals within 2–3 hours of recumbency, and tobacco/alcohol cessation. Blanket elimination diets are not recommended; trigger avoidance is individualized.

Escalation: for partial response, ACG supports optimizing timing/adherence, switching PPI agents, or twice-daily dosing; potassium-competitive acid blockers (vonoprazan) are an alternative for erosive disease. Truly refractory symptoms mandate objective testing (pH-impedance) before further acid suppression. Baclofen reduces tLESRs when non-acid reflux predominates. Long-term maintenance PPI is indicated for LA grade C/D esophagitis and Barrett's; NERD can be stepped down to on-demand therapy.

Definitive/surgical: laparoscopic Nissen (or partial) fundoplication or magnetic sphincter augmentation for objectively confirmed GERD with refractory or regurgitation-predominant disease, or patient preference against lifelong drugs. Roux-en-Y gastric bypass is the preferred antireflux operation in obesity. Preoperative pH monitoring off PPI plus manometry is mandatory.

Avoid: a full 360° wrap in achalasia or absent contractility (scleroderma) — causes obstructive dysphagia; routine metoclopramide (tardive dyskinesia, FDA boxed warning); and all ACE inhibitors and other pregnancy-contraindicated drugs are irrelevant here — in pregnancy use antacids/sucralfate, then H2RAs, then PPIs.